Antagonistic activity of some phenothiazine derivatives against neurohumoral transmitters.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D002746:Chlorpromazine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005476:Fluphenazine / Q000494:pharmacology; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists; D066298:In Vitro Techniques; D018377:Neurotransmitter Agents / Q000037:antagonists & inhibitors*; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010546:Perphenazine / Q000494:pharmacology; D010640:Phenothiazines / Q000494:pharmacology; D011346:Prochlorperazine / Q000494:pharmacology; D011395:Promazine / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D012702:Serotonin Antagonists; D013881:Thioridazine / Q000494:pharmacology; D014268:Trifluoperazine / Q000494:pharmacology; D014273:Triflupromazine / Q000494:pharmacology; D014291:Trimeprazine / Q000494:pharmacology
D014150:Antipsychotic Agents; D006634:Histamine H1 Antagonists; D018377:Neurotransmitter Agents; D010640:Phenothiazines; D011941:Receptors, Adrenergic; D012702:Serotonin Antagonists; D014268:Trifluoperazine; D014291:Trimeprazine; D010546:Perphenazine; D013881:Thioridazine; D000109:Acetylcholine; D011395:Promazine; D014273:Triflupromazine; D005476:Fluphenazine; D002746:Chlorpromazine; D009638:Norepinephrine; D011346:Prochlorperazine